Susmed: Independent Officer Notification Form
Susmed: Matters relating to business plans and growth potential
Susmed: Notice of Convocation of the 9th Annual General Meeting of Shareholders and Shareholders' Meeting Materials
Susmed: Notice of approval application for partial changes in manufacturing and sales approval matters for the “SustMed Med CBT-i Insomnia Disorder App”
Susmed: Notice regarding transition to a company with an Audit and Supervisory Committee, executive personnel affairs, and partial changes to the Articles of Incorporation
Susmed: Financial results presentation materials for the period ending June 2024.
Susmed: Fiscal year ending June 2024, financial statement text (based on Japan standards) (non-consolidated)
Susmed: Announcements of individual stocks regarding the determination of the issuance of stock options (subscription rights).
Susmed: Announcements of individual stocks regarding the issuance of single stock options
Susmed: Confirmation letter
Susmed: Presentation of financial results for the 3rd quarter of the fiscal year ending 2024/6
Susmed: Summary of financial results for the 3rd quarter of the fiscal year ending 2024/6 [Japanese GAAP] (unconsolidated)
Susmed: Quarterly Report - 9th Quarter 3rd Quarter (2024/01/01 - 2024/03/31)
Susmed: Notice Concerning Determination of Issuance Details of Stock Options (Stock Acquisition Rights)
Susmed: Notice Concerning Issuance of Stock Options (Stock Acquisition Rights)
Susmed: Notice regarding the extinction of the 8th Stock Acquisition Rights (Trust Stock Options)
SustainMed: Confirmation Letter
SustainMed: Quarterly Report - 9th Quarter (2023/10/01 - 2023/12/31)
Susmed: Financial results presentation materials for the 2nd quarter of the fiscal year ending 2024/6
Susmed: Notice regarding full-year earnings forecasts
No Data
No Data